gip vs glp-1 Gastrointestinal Incretins—Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-like Peptide-1 (GLP-1) beyond Pleiotropic Physiological Effects Are Involved in Pathophysiology of Atherosclerosis and Coronary Artery Disease—State of the Art New strategies for the treatment
Description
Nikolaidis LA, Elahi D, Hentosz T, Doverspike A, Huerbin R, Zourelias L, Stolarski C, Shen YT, Shannon RP: Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy
Step one: the online health assessment Everything starts with an online intake form that takes roughly five minutes
Bariatric procedures or surgery were go-to options for many people prior to GLP-1 medications
Perioperative management of long-acting glucagon-like peptide-1 (GLP-1) receptor agonists: concerns for delayed gastric emptying and pulmonary aspiration
Anna Lembke, a Stanford University addiction medicine specialist, told The Associated Press that while some clinicians are already prescribing GLP-1s off-label for addiction, the drugs dont work the same way for everyone and carry risks, including gastrointestinal side effects, pancreatitis and kidney conditions, that must be weighed
doi: 10.1210/jcem-24-10-1076 [DOI] [PubMed] [Google Scholar] 4
